Sonoma Pharmaceuticals (SNOA) Long-Term Investments (2014 - 2015)
Sonoma Pharmaceuticals (SNOA) posted quarterly Long-Term Investments of $4.5 million for Q1 2015, down 55.29% year-over-year from $10.1 million in Q1 2014, and down 17.49% quarter-over-quarter from $5.5 million in Q4 2014.
Sonoma Pharmaceuticals (SNOA) Long-Term Investments (2014 - 2015) Analysis & Trends
Sonoma Pharmaceuticals' Long-Term Investments history runs 2 years deep, the most recent figure standing at $4.5 million for Q1 2015.
- In Q1 2015, Long-Term Investments fell 55.29% year-over-year to $4.5 million; the TTM figure through Mar 2015 stood at $4.5 million (down 55.29% YoY), while the FY2015 annual figure was $4.5 million, down 55.29% from the prior year.
- Long-Term Investments for Q1 2015 stood at $4.5 million, down from $5.5 million in the prior quarter.
- The five-year high for Long-Term Investments was $10.2 million in Q1 2014, with the low at $4.5 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | Sonoma Pharmaceuticals | 5.15 Mn | -184,359.87 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 4.54 Mn |
| Dec 31, 2014 | 5.50 Mn |
| Sep 30, 2014 | 10.15 Mn |
| Mar 31, 2014 | 10.15 Mn |